• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1800098 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view
JYSB1400249 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2014-12-10 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-12-08 view
JYSB1900366 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-01-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-01-08 view
JYHB1600546 替米沙坦片 telmisartan Tablet Chemical Drugs Supplementary Application 2016-05-06 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2017-08-29 view
JYSB1700169 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYHB1401350 达比加群酯胶囊 dabigatran etexilate Capsule Chemical Drugs Supplementary Application 2014-10-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-11-15 view
JYSB1800119 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYSZ1500003 注射用阿替普酶 alteplase Lyophilized Biological Products License Renew 2015-02-11 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-12-08 view
JYHZ2000026 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-03-11 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JYSB1700051 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-05-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2017-07-17 view
JYSB1800096 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-05-14 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-02-02 view
JYHB1401352 达比加群酯胶囊 dabigatran etexilate Capsule Chemical Drugs Supplementary Application 2014-10-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-11-15 view
JYSB1900367 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2020-01-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-01-08 view
JYHB1600548 替米沙坦片 telmisartan Tablet Chemical Drugs Supplementary Application 2016-04-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2017-08-29 view
JYSB1700170 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2017-10-20 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-23 view
JYSB1800118 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2018-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-11-28 view
JYHB1401709 丁溴东莨菪碱注射液 scopolamine butylbromide Injection Chemical Drugs Supplementary Application 2014-12-23 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2016-07-25 view
JYHZ2000027 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-02-25 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JXHL1600050 尼达尼布软胶囊 nintedanib Soft capsules Chemical Drugs Import Drug Application 2016-05-10 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-03-09 view
JYSB1900204 注射用阿替普酶 alteplase Lyophilized Biological Products Supplementary Application 2019-09-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-12-05 view